v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Net revenue $ 819,799 $ 777,882
Revenue, Product and Service [Extensible Enumeration] Health Care, Patient Service [Member] Health Care, Patient Service [Member]
Costs and expenses:    
Cost of net revenue $ 708,298 $ 657,444
Cost, Product and Service [Extensible Enumeration] Health Care, Patient Service [Member] Health Care, Patient Service [Member]
General and administrative expenses $ 95,908 $ 86,854
Depreciation and amortization, excluding patient equipment depreciation 10,104 10,414
Total costs and expenses 814,310 754,712
Operating income 5,489 23,170
Interest expense, net 25,594 28,399
Loss before income taxes (20,105) (5,229)
Income tax (benefit) expense (5,232) 850
Net loss (14,873) (6,079)
Income attributable to noncontrolling interest 1,167 1,128
Net loss attributable to AdaptHealth Corp. $ (16,040) $ (7,207)
Weighted average common shares outstanding - basic (in shares) 135,779 134,799
Weighted average common shares outstanding - diluted (in shares) 135,779 134,799
Basic net loss per share (in dollars per share) $ (0.12) $ (0.05)
Diluted net loss per share (in dollars per share) $ (0.12) $ (0.05)